Cosentyx unoready 300 MG pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F1BUF
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,787
Award facts
- Contract value 100% obligated
- $10,787.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $10,787.40 by the Defense Logistics Agency on January 21, 2026, for the supply of Cosentyx (secukinumab) 300 mg pens. This firm fixed-price delivery order, which represents a competitive award with no set-aside designation, is due for completion by January 22, 2026. The award is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, a single-award IDC valued at up to $999,999,999.00 through December 31, 2031, which serves as the comprehensive vehicle for delivering pharmaceutical products and medical supplies to support military healthcare programs globally.
This delivery order supports the Defense Logistics Agency's mission to supply essential medical commodities to military treatment facilities and other federal healthcare systems. Cosentyx, an immunosuppressant biologic used to treat autoimmune conditions such as psoriasis and rheumatoid arthritis, represents the type of specialty pharmaceutical product routinely procured through the DLA's pharmaceutical supply chain. AmerisourceBergen's extensive federal contract portfolio and established relationship with DLA through its prime vendor contract demonstrate the company's critical role in maintaining the availability of brand-name and generic medications required by military and veteran healthcare programs.
Quick answers
Who was awarded contract SPE2DR26F1BUF?
SPE2DR26F1BUF was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 21, 2026.
How much is contract SPE2DR26F1BUF worth?
The government has obligated $10,787 on SPE2DR26F1BUF.
Is contract SPE2DR26F1BUF an order under another contract?
Yes. SPE2DR26F1BUF is a delivery order under SPE2DR25D2012, an indefinite delivery contract.
Was contract SPE2DR26F1BUF competed?
The extent of competition for SPE2DR26F1BUF was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award